Peer Review History
| Original SubmissionMay 30, 2020 |
|---|
|
PONE-D-20-16381 Experimental Evaluation of Stiffening Effect Induced by UVA/Riboflavin Corneal Cross-Linking Using Intact Porcine Eye Globes PLOS ONE Dear Dr. Li, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 10 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Craig Boote, PhD Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please note that PLOS ONE has specific guidelines on software sharing (http://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-software) for manuscripts whose main purpose is the description of a new software or software package. In this case, new software must conform to the Open Source Definition (https://opensource.org/docs/osd) and be deposited in an open software archive. Please see http://journals.plos.org/plosone/s/materials-and-software-sharing#loc-depositing-software for more information on depositing your software. 3. We noticed you have some minor occurrence of overlapping text with previous publications, which needs to be addressed. In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed. 4. Please amend your Data availability statement to provide information of where the data used in the study can be found. We note that the data does not appear to have been provided as Supplemental information. Can other researchers obtain the dataset used? 5. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This study uses an inflation system to examine the mechanical properties of cornea after UVA crosslinking. It is unclear what is the actual goal of the study. There are have been numerous studies that have shown UVA crosslinking results in increases in stiffness of cornea so other than using a different measurement technique its not clear why this data is valuable. In addition, the description of the techniques and instrumentation used need to be clearer. Specific comments are listed below. 1) In the introduction the authors state "This study was also the first one to consider the stiffness of cornea as a whole following CXL." Its not clear what the authors mean here. There have been studies that have used whole corneas to evaluate CXL. 2) In section 2.1 the authors state "The internal eye components were removed through the posterior pole with a 14G needle." What components? Is it just humour or are they removing the lens, retina, etc., 3) How large are the speckles that are applied to the eye? Do they remain attached to the same points on the eye or can the move independently? If checked, this should be stated. 4) The test rig in figure 1 should be labelled 5) There is no explanation as to how the pressure was applied, controlled or measured? 6) How was the thickness measured? 7) It is unclear how the recorded images are incorporated into the model. This should be explained better. 8) The authors should explain why they choose the Ogden model 9) In the results section the authors state "The average values of μ were 0.02 ± 0.012 and 0.01 ± 0.002 (p = 0.157), and the average values of α were 94.3 ± 28.9 and 65.1 ± 15.9 (p = 0.037) in CXL and PBS control, respectively". Should these values have units, particularly if μ represents shear modulus? 10) It is unclear how the tangent modulus was calculated. This should be explained in the methods. Reviewer #2: This manuscript investigated the effects of cross-linking on the stiffness of cornea through inflation tests and inverse finite element modelling. The manuscript is well structured but I have several points that need to be considered. 1. The technique used to measure the corneal thickness should be introduced in the method section. 2. In the finite element model, the limbus region were restricted in the X, Y and Z direction. This limitation should also be acknowledged in the discussion section. 3. In section 2.3, last sentence. “… figure 3.6 allows …”, there is no figure 3.6 in the manuscript. I believe it should be Figure 1b. 4. In section 2.7, there is no Equation 3.2. 5. The data presented in Table 1 is inconsistent with those in Figure 3. For example, the thickness of central cornea in control and CXL groups were 1.3 and 0.95mm in Table 1, but they seems to have different values in Figure 3. Please double check those plots. 6. In the Results section (line 5-6 of first paragraph), the first group of data should be those of the control group, not the CXL group. Please check the whole manuscript thoroughly. 7. Section 2.3, ‘angler’ should be ‘angle’ ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Experimental Evaluation of Stiffening Effect Induced by UVA/Riboflavin Corneal Cross-Linking Using Intact Porcine Eye Globes PONE-D-20-16381R1 Dear Dr. Li, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Craig Boote, PhD Academic Editor PLOS ONE Additional Editor Comments: Thank you for your efforts in addressing the reviewers' comments in detail. I am happy to recommend publication without further referral to the reviewers in this case. |
| Formally Accepted |
|
PONE-D-20-16381R1 Experimental Evaluation of Stiffening Effect Induced by UVA/Riboflavin Corneal Cross-Linking Using Intact Porcine Eye Globes Dear Dr. Li: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr Craig Boote Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .